Blog

Our blog is a platform for members and partners to share their views and tell us about their work and interests. If you have any ideas for articles then get in touch.

Introduction to the Finance Committee

28 Apr 2017 by Mike Poole published April 2017

The Finance Committee at the British Pharmacological Society may seem a little mysterious in comparison with those committees more directly relevant to members’ areas of primary interest and expertise. This article will give a bit of an insight into what the Committee is really like, the value it adds to the work of the Society and the experience of members who serve on it.

Meetings update

28 Apr 2017 by Niall Hyland in Meetings update published April 2017

The Society's vice-president (meetings) and head of meetings and events reflect on some highlights from 2016 and look forward to a busy programme of meetings in 2017.

The Society’s Advisory Groups – guest starring the new International Advisory Group members

20 Apr 2017 by Teesha Bhuruth published April 2017

The British Pharmacological Society is proud to have four Advisory Groups to represent the interests and views of its diverse membership. The Advisory Groups make a valued contribution to the Society’s activities by ensuring that members' needs are listened to and addressed. The success of these groups has paved way for the formation of a new group in 2017: the International Advisory Group.

Ambassadors update: Extending and celebrating the importance of pharmacology in London

20 Apr 2017 by Aisah Aubdool published April 2017

Ahead of Women’s History Month in March, we organised a Women in Pharmacology event to celebrate the achievements of female pharmacologists at King’s College London (KCL). This event was a collaboration between British Pharmacological Society, KCL Bioscience Students’ Association and KCL Pharmacological Society. 

The AllTrials campaign. Bring out your unreported trials!

18 Apr 2017 by Síle Lane published April 2017

Clinical trials are at the heart of modern medical research. They are the best means we have of testing whether a medicine is safe and whether it works. Around the world, pharmaceutical companies, universities, government research institutes and medical charities run tens of thousands of trials every year. So it’s a problem that the results of around half of all clinical trials currently remain hidden.

Using animals in research? It’s time to refine!

18 Apr 2017 by Elliot Lilley, Sarah Bailey, Emma Robinson published April 2017

During the last Olympics, the Team GB medal haul was their best since 1908. Many commentators attributed this to the ‘aggregation of marginal gains’. We can apply this concept to refining techniques in animal research. In this article, we focus on the ‘R’ of refinement and present examples of how small changes to everyday procedures can be implemented to refine experimental procedures.

Editorial

23 Nov 2016 by in Editorial published November 2016

It has certainly been a very busy year, and I personally cannot believe that we are close to the festive holidays already… Where has this year gone?

Your Society

23 Nov 2016 by Jonathan Bruun in Your Society published November 2016

It’s hard to believe that when this is published, we will be approximately a month away from Pharmacology 2016. The team at the Schild Plot is focused on delivering another lively and successful meeting, with many new activities planned. 

What’s next for UK in vivo education and training? Lessons from the Integrative Pharmacology Fund

23 Nov 2016 by Michael Collis, Dave Lewis, Anna Zecharia published November 2016

In vivo knowledge and skills have always been essential in academic research labs that investigate basic physiology, ageing, diseases and their pharmacological treatments. Their importance has increased as researchers have sought to understand the functional significance of genomic information, particularly through the use of transgenic models.

Banning psychoactive substances is not enough, we need education too

23 Nov 2016 by Lisa Lione published November 2016

Novel Psychoactive Substances, also referred to as ‘legal highs’, represent a bewildering array of unregulated psychoactive compounds, marketed globally as legal alternatives to well-known controlled drugs. 

Science is global

23 Nov 2016 published November 2016

The British Pharmacological Society is proud to be a global community at the heart of pharmacology: our journals have a global readership, a fifth of our membership is international, and we represent scientists from more than 60 countries worldwide.

• >
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• >